Search
Spotlight
CME Opportunities
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Inside the Clinic: Global Insights: Multidisciplinary Care of Stage III NSCLC
EP. 1: The Multidisciplinary Care of Stage III NSCLC
May 2nd 2019
EP. 2: Overview of Molecular Testing in Stage III NSCLC
May 2nd 2019
EP. 3: Tissue Collection: In-House Sampling and Reflex Testing
May 2nd 2019
EP. 4: Ensuring Reliable Results From Molecular Testing
May 2nd 2019
EP. 5: Assay Validation and Interdisciplinary Communication
May 2nd 2019
EP. 6: Immunotherapy in Stage III NSCLC
May 2nd 2019
EP. 7: How Durvalumab Has Changed the Standard of Care
May 2nd 2019
EP. 8: Impact of the PACIFIC Study Updated Analysis
May 2nd 2019
EP. 9: Importance of PD-L1 Status in Treating Stage III NSCLC
May 2nd 2019
EP. 10: Recommended Settings for Durvalumab Treatment
May 2nd 2019
NEXT PAGE
<
1
2
>
PREVIOUS PAGE
x